ADCYN

Serial Number 88216079
606

Registration Progress

Application Filed
Dec 4, 2018
Under Examination
Apr 2, 2019
Approved for Publication
Feb 5, 2019
Published for Opposition
Feb 5, 2019
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ADCYN
Previous Owner: Glenmark Pharmaceuticals Inc., USA
Classes: 005

Trademark Image

ADCYN

Basic Information

Serial Number
88216079
Filing Date
December 4, 2018
Published for Opposition
February 5, 2019
Abandonment Date
November 4, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Nov 4, 2019
Classes
005

Rights Holder

Glenmark Pharmaceuticals Inc., USA

03
Address
750 Corporate Dr.
Mahwah, NJ 07430

Ownership History

Glenmark Pharmaceuticals Inc., USA

Original Applicant
03
Mahwah, NJ

Glenmark Pharmaceuticals Inc., USA

Owner at Publication
03
Mahwah, NJ

Legal Representation

Attorney
Maxim Voltchenko

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

10 events
Date Code Type Description Documents
Nov 4, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Nov 4, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 2, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Feb 5, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 5, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 16, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 26, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 21, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 21, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 7, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Dermatological pharmaceutical products; Pharmaceutical preparations for the prevention and treatment of the inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis; Corticosteroid preparations
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005